-
R275595-25mgProduct Description:A cell-permeable and reversible inhibitor of protein kinase C δ (PKCδ, IC50 = 3-6 µM) and PKCΘ isozymes. Also inhibits PKCα, PKCβ, and PKCγ isoforms, but with significantly reduced potency (IC50 = 30-42 µM). Has reduced
-
R275595-50mgProduct Description:A cell-permeable and reversible inhibitor of protein kinase C δ (PKCδ, IC50 = 3-6 µM) and PKCΘ isozymes. Also inhibits PKCα, PKCβ, and PKCγ isoforms, but with significantly reduced potency (IC50 = 30-42 µM). Has reduced
-
R275595-5mgProduct Description:A cell-permeable and reversible inhibitor of protein kinase C δ (PKCδ, IC50 = 3-6 µM) and PKCΘ isozymes. Also inhibits PKCα, PKCβ, and PKCγ isoforms, but with significantly reduced potency (IC50 = 30-42 µM). Has reduced
-
R426123-1mlProduct Description:A cell-permeable and reversible inhibitor of protein kinase C δ (PKCδ, IC50 = 3-6 µM) and PKCΘ isozymes. Also inhibits PKCα, PKCβ, and PKCγ isoforms, but with significantly reduced potency (IC50 = 30-42 µM). Has reduced
-
R136626-100mgPotent, selective dopamine D 1 receptor antagonist.
-
R136626-1gPotent, selective dopamine D 1 receptor antagonist.
-
R136626-250mgPotent, selective dopamine D 1 receptor antagonist.
-
R136626-25gPotent, selective dopamine D 1 receptor antagonist.
-
R136626-500mgPotent, selective dopamine D 1 receptor antagonist.
-
R136626-5gPotent, selective dopamine D 1 receptor antagonist.
-
R334597-10mgApplication:Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
-
R334597-1mgApplication:Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.